97 related articles for article (PubMed ID: 311079)
1. [Role of chromogenic substrates in the study of blood coagulation and fibrinolysis].
Rutllant ML
Sangre (Barc); 1978; 23(6):858-63. PubMed ID: 311079
[No Abstract] [Full Text] [Related]
2. INTRAVASCULAR CLOTTING AND SPONTANEOUS FIBRINOLYSIS.
KOLLER F
Acta Haematol; 1964 Apr; 31():239-46. PubMed ID: 14169390
[No Abstract] [Full Text] [Related]
3. [Use of chromogenic substrates for the diagnosis of blood coagulation and fibrinolytic disorders].
Bokarev IN; Butorov VN; Loginov LE
Ter Arkh; 1981; 53(2):118-24. PubMed ID: 6452714
[No Abstract] [Full Text] [Related]
4. INfluence of Pseudomonas aeruginosa proteases on prothrombin, plasminogen and fibrinogen.
Pulverer G; Wegrzynowicz Z; Ko HL; Jeljaszewicz J
Zentralbl Bakteriol A; 1980; 248(1):99-109. PubMed ID: 6781167
[TBL] [Abstract][Full Text] [Related]
5. [Hemostatic mechanisms and malignant tumors].
Kase F; Pospísil J; Hlousková D
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):809-30. PubMed ID: 2419210
[TBL] [Abstract][Full Text] [Related]
6. Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikrein-kinin systems.
Friberger P
Scand J Clin Lab Invest Suppl; 1982; 162():1-298. PubMed ID: 6221396
[No Abstract] [Full Text] [Related]
7. The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro.
Torbet J
Thromb Haemost; 1995 May; 73(5):785-92. PubMed ID: 7482404
[TBL] [Abstract][Full Text] [Related]
8. [The fibrinolytic activity in Seegers' cattle prothrombin preparations. A contribution to the problem of the activation of cattle prothrombin by plasmin].
Andrassy K; Egbring R; Egli H
Thromb Diath Haemorrh; 1969 Nov; 22(2):377-90. PubMed ID: 4245334
[No Abstract] [Full Text] [Related]
9. Full and partial deuterium solvent isotope effect studies of alpha-thrombin-catalyzed reactions of natural substrates.
Zhang D; Kovach IM
J Am Chem Soc; 2005 Mar; 127(11):3760-6. PubMed ID: 15771510
[TBL] [Abstract][Full Text] [Related]
10. Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.
Weitz JI; Cruickshank MK; Thong B; Leslie B; Levine MN; Ginsberg J; Eckhardt T
J Clin Invest; 1988 Nov; 82(5):1700-7. PubMed ID: 3141481
[TBL] [Abstract][Full Text] [Related]
11. [Role of proteases, plasminogen activators, fibrin fibrinogen degradation products and fibrinopeptides in the growth and development of neoplasms and neoplasm metastases].
Farbiszewski R
Postepy Hig Med Dosw; 1984; 38(2):133-55. PubMed ID: 6393101
[No Abstract] [Full Text] [Related]
12. [Evaluation of selected parameters of blood coagulation and the fibrinolysis system in patients undergoing total hip replacement].
Sokołowska B; Piecuch W; Walter-Croneck A; Dmoszyńska A; Furmanik F
Przegl Lek; 2002; 59(7):502-8. PubMed ID: 12516238
[TBL] [Abstract][Full Text] [Related]
13. [Use of chromogenic substrates for estimation of indicators of kallikrein-kinin and blood coagulation systems in blood plasma of patients with nephrotic syndrome].
Baskova IP; Paskhina TS; Poliantseva LR; Iakubovskaia RI; Tiero A
Vopr Med Khim; 1983; 29(5):96-9. PubMed ID: 6557709
[TBL] [Abstract][Full Text] [Related]
14. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
15. [Blood coagulation and fibrinolysis in alcoholism].
Sumi H
Nihon Rinsho; 1988 Aug; 46(8):1769-77. PubMed ID: 3236444
[No Abstract] [Full Text] [Related]
16. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
Gram J
Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
[TBL] [Abstract][Full Text] [Related]
17. The effects of ancrod, the coagulating enzyme from the venom of Malayan pit viper (A. rhodostoma) on prothrombin and fibrinogen metabolism and fibrinopeptide A release in man.
Bell WR; Shapiro SS; Martinez J; Nossel HL
J Lab Clin Med; 1978 Apr; 91(4):592-604. PubMed ID: 641385
[TBL] [Abstract][Full Text] [Related]
18. Substitution of tyrosine for phenylalanine in fibrinopeptide A results in preferential thrombin cleavage of fibrinopeptide B from fibrinogen.
Rooney MM; Mullin JL; Lord ST
Biochemistry; 1998 Sep; 37(39):13704-9. PubMed ID: 9753458
[TBL] [Abstract][Full Text] [Related]
19. [The state of prothrombin, plasminogen and fibrinogen in the newborn infant].
Potron G; Droulle C; Behar C; Leroux B; Ledoyen MP; Mascre W
Pathol Biol (Paris); 1975 Dec; 23 suppl():56-62. PubMed ID: 4759
[TBL] [Abstract][Full Text] [Related]
20. Effects of thrombin infusions upon 131-I-labelled fibrinogen in dogs.
Nordström S; Zetterqvist E
Acta Physiol Scand; 1968; 72(1):85-99. PubMed ID: 5301454
[No Abstract] [Full Text] [Related]
[Next] [New Search]
